Change in CVD risk factors | MVPA guidelinesb | P | P of inter-action | |
---|---|---|---|---|
Not meet | Meet | |||
log Fasting insulin, mg/dl | Ā | Ā | Ā | 0.01 |
āDominican | 0.25 (0.15, 0.35) | 0.07 (ā0.03, 0.17) | 0.006 | Ā |
āCentral American | 0.21 (0.15, 0.27) | 0.12 (0.02, 0.22) | 0.59 | Ā |
āCuban | 0.14 (0.06, 0.22) | 0.06 (āā0.06, 0.18) | 0.14 | Ā |
āMexican | 0.23 (0.17, 0.29) | 0.24 (0.18, 0.30) | 0.68 | Ā |
āPuerto Rican | 0.19 (0.11, 0.27) | 0.13 (0.05, 0.21) | 0.25 | Ā |
āSouth American | 0.18 (0.10, 0.26) | 0.10 (0.00, 0.20) | 0.05 | Ā |
āMixed/other | 0.25 (0.11, 0.39) | 0.44 (0.24, 0.64) | 0.09 | Ā |
log HOMA-IR | Ā | Ā | Ā | 0.04 |
āDominican | 0.29 (0.17, 0.41) | 0.12 (0.02, 0.22) | 0.03 | Ā |
āCentral American | 0.24 (0.16, 0.32) | 0.15 (0.03, 0.27) | 0.73 | Ā |
āCuban | 0.15 (0.07, 0.23) | 0.07 (ā0.05, 0.19) | 0.13 | Ā |
āMexican | 0.28 (0.22, 0.34) | 0.29 (0.23, 0.35) | 0.89 | Ā |
āPuerto Rican | 0.26 (0.16, 0.36) | 0.18 (0.08, 0.28) | 0.25 | Ā |
āSouth American | 0.21 (0.13, 0.29) | 0.12 (0.00, 0.24) | 0.08 | Ā |
āMixed/other | 0.29 (0.13, 0.45) | 0.52 (0.30, 0.74) | 0.02 | Ā |